WallStreetZenWallStreetZen

NASDAQ: AYTU
Aytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?

Insider buying vs selling

Have Aytu Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Greg PyszczymukaChief Commerical Officer2023-06-1612,000$1.87
$22.43kBuy
Joshua R. DisbrowChief Executive Officer2023-06-1414,000$1.86
$26.08kBuy

1 of 1

AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AYTU insiders and whales buy or sell their stock.

AYTU Shareholders

What type of owners hold Aytu Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC198.99%11,078,956$34.12MInsider
Cerecor Inc174.46%9,713,068$29.92MInsider
James B. Wiegand42.04%2,340,659$7.21MInsider
Ampio Pharmaceuticals Inc22.03%1,226,407$3.78MInsider
Christopher Brooke20.96%1,167,147$3.59MInsider
Nantahala Capital Management LLC19.52%1,086,812$3.35MInsider
Nantahala Capital Management LLC19.52%1,086,812$3.35MInstitution
Carl Dockery16.09%895,925$2.76MInsider
David A. Green9.36%521,250$1.61MInsider
Stonepine Capital Management LLC8.49%472,469$1.46MInstitution

1 of 3

AYTU vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU5.65%94.35%Net Buying
FLGC13.71%85.60%Net Selling
TLPH8.65%91.35%Net BuyingNet Buying
ACOR1.11%98.89%
KALA1.06%98.94%Net SellingNet Selling

Aytu Biopharma Stock Ownership FAQ

Who owns Aytu Biopharma?

Aytu Biopharma (NASDAQ: AYTU) is owned by 31.78% institutional shareholders, 531.00% Aytu Biopharma insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11.08M shares representing 198.99% of the company. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $34.12M.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.